Centessa Pharmaceuticals Investor Relations Material
Latest events
Centessa Pharmaceuticals Poster Presentation
11 Jun, 2025
Corporate Presentation
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Centessa Pharmaceuticals plc
Access all reports
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company dedicated to discovering, developing, and delivering transformative medicines. Established in 2020, the company focuses on developing a wide range of innovative treatments across various therapeutic areas, including rare diseases and immuno-oncology. Centessa Pharmaceuticals is headquartered in Altrincham, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Centessa Pharmaceuticals plc
Corporate Presentation
Centessa Pharmaceuticals plc
Corporate Presentation
Centessa Pharmaceuticals plc
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
CNTA
Country
🇺🇸 United States